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Abstract
Background: The emergence and worldwide spread of carbapenemase-producing Enterobacteriaceae is of great
concern to public health services. The aim of this study was to investigate the occurrence of carbapenemase-producing
Enterobacteriaceae in the community in Switzerland.
Findings: One thousand and eighty-six stool samples of healthy humans (staff members of a food-processing company
which were screened for the occurrence of salmonellae) were collected in September 2014. After an initial
enrichment-step, carbapenemase-producing Enterobacteriaceae were isolated from the carbapenem-containing
selective medium SUPERCARBA II. Grown colonies from 11 samples were screened by PCR for the presence of blaKPC,
blaNDM, blaOXA-48 and blaVIM. A single OXA-48-producing Escherichia coli was detected. Phylogenetic grouping and
multi-locus sequence typing (MLST) revealed that this strain belonged to D:ST38, a type which had been previously
reported in the UK, France, Lebanon and Egypt.
Conclusions: The results of this study show that OXA-48-producing Enterobacteriaceae have started to spread into the
community in Switzerland, and a continuous monitoring is necessary to better understand their dissemination in the
human population as well as in animals and the environment.
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Findings
Most carbapenemases identified in Enterobacteriaceae
hydrolyze almost all β-lactam antibiotics, including car-
bapenems, with the exception of OXA-48 that weakly
hydrolyses carbapenems but paradoxally spares broad-
spectrum cephalosporins. Currently, the most prevalent
carbapenemases found among Enterobacteriaceae world-
wide include the Ambler class A carbapenemase KPC,
the class B metallo-β-lactamases (MBLs) of the IMP-,
NDM- or VIM-type, and the class D OXA-48-like oxa-
cillinases [1].
Carbapenemase-producing Enterobacteriaceae (mainly
Klebsiella pneumoniae and Escherichia coli) were first
described in Europe in the 1990s, and since then they
have been increasingly reported especially in clinical set-
tings. The emergence of these bacteria is of great con-
cern to public health services because they are often also
co-resistant to many other antibiotic classes and thus,
only few treatment options remain [2]. Their dissemin-
ation into the community and the environment is only a
matter of time.
Two years ago, we reported that there was no evidence
for the dissemination of carbapenemase-producing En-
terobacteriaceae in the community in Switzerland [3].
The aim of this study was to survey the current situation
for the presence of carbapenemase-producing Entero-
bacteriaceae in healthy humans in Switzerland.
In the context of a yearly routine fecal screening for
salmonellae, stool samples were obtained from 3200
employees of a meat-processing company. This com-
pany consists of eight countrywide processing plants
and employs people from the surrounding urban areas.
Each staff member was tested only once. For this study,
1086 samples were randomly selected. The samples were
tested for the presence of KPC-, NDM-, OXA-48, or VIM-
type carbapenemase-producing Enterobacteriaceae. A
loopful of each sample was enriched for 24 hours at 37°C
in 5 mL of Enterobacteriaceae Enrichment (EE) broth
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without antibiotic (Oxoid, Ltd, Basingstoke, Hampshire,
England). The enrichment culture was thereafter streaked
onto a modified SUPERCARBA agar medium selecting for
bacteria with reduced susceptibility to ertapenem, which is
the most sensitive marker for carbapenemase production.
The SUPERCARBA II medium differs from the previously
published SUPERCARBA [4] since its basis is made of
Trypticase Soy agar (rather than Drigalski) and con-
tains vancomycin (10 μg/ml) and amphotericin B
(5 μg/ml) in order to prevent the growth of Gram pos-
itives or fungi. SUPERCARBA, ideally complemented
by the RAPIDEC® CARBA NP test (bioMérieux Ltd),
has been shown to be most suited to detect carbape-
nemase producers, since it exhibits a very high specifi-
city and a very high sensitivity even for those OXA-
48-producing strains that often exhibit low MICs of
carbapenems [4].
Growth of oxidase negative colonies was obtained for
eleven selective plates and those colonies were screened
by PCR for the presence of blaKPC, blaNDM, blaOXA-48
and blaVIM using primers described previously [5,6].
Species identification using API ID 32 E (bioMérieux,
Marcy l’Etoile, France) and multi-locus sequence typing
[7] was performed with strains positive for any of the
above listed genes. Phylogenetic classification was per-
formed as described previously [8].
A single isolate (JU-S-791) was found positive for the
blaOXA-48 carbapenemase gene (100% identity after se-
quencing), which corresponded to a shedding prevalence
of carbapenemase-producing Enterobacteriaceae in the
tested collective of 0.09%. The Oxa-48-positive individ-
ual, a Turkish citizen born and raised in Switzerland,
had no history of hospital admissions and no history of
recent antibiotic therapy but reported annual visits to
Turkey and a journey to Italy one month prior to sam-
pling. The OXA-48 producer was identified as E. coli se-
quence type (ST) 38 and belonged to the extraintestinal
pathogenic phylogenetic group D.
Susceptibility testing was performed by the agar diffu-
sion method, using antibiotic disks (Becton Dickinson
and Company, Maryland, USA) according to the manu-
facturers' protocols. Minimal inhibitory concentrations
(MIC) of imipenem and cefotaxime, ceftazidime, and ce-
fepime alone and in combination with clavulanic acid
were determined by Etest strips (bioMérieux, Marcy
l’Etoile, France). Results were interpreted according to
the criteria of the Clinical and Laboratory Standards In-
stitute (CLSI) [9].
The MIC of imipenem was 0.5 μg/ml, which is still
below the susceptibility breakpoint defined by CLSI.
Class D carbapenem-hydrolyzing β-lactamases possess
weak carbapenemase-activity and usually do not confer a
high-level resistance phenotype unless the strain exhibits
additional permeability defects [10,11].
Although OXA-48-producers only very poorly
hydrolyze expanded-spectrum cephalosporins, the strain
JU-S-791 displayed an extended-spectrum β-lactamase
(ESBL) phenotype (MIC of cefotaxime >16 μg/ml, and
MIC of cefotaxime plus clavulanic acid = 0.5 μg/ml) and
additionally tested resistant in the disk diffusion test to
gentamicin (zone diameter 10 mm), nalidixic acid,
(6.5 mm), sulfamethoxazole (6 mm) and trimethoprim
(6 mm). It was susceptible in the disk diffusion test to
ciprofloxacin (27 mm), tetracycline (19 mm), chloram-
phenicol (25 mm) and kanamycin (19 mm). Screening
for blaCTX-M, blaSHV and blaTEM as described previously
[12], revealed that the strain, in addition to the blaOXA-
48 gene, co-harbored the ESBL gene blaCTX-M-24 and the
narrow-spectrum β-lactamase gene blaTEM-1. In order to
evaluate whether the blaOXA-48 gene could be trans-
ferred, conjugation experiments were performed using a
standardized method for liquid mating techniques, as
described elsewhere [13]. However, they systematically
failed, suggesting a chromosomal location of this gene,
and no further attempts at plasmid detection were
undertaken.
OXA-48 was first described 2001 in a K. pneumoniae
isolate from a patient in Istanbul, Turkey. It is suggested
that the main reservoirs of OXA-48-harbouring K. pneu-
moniae and E. coli are in North African countries and
Turkey [11]. Nowadays, OXA-48 producing Enterobacteri-
aceae are widely disseminated throughout many European
countries and have led to several hospital outbreaks [11].
In particular, the spread of the blaOXA-48 gene in commu-
nity isolates but also in the environment has been demon-
strated in Morocco [14,15]. The successful spread of
blaOXA-48 is linked to a single self-conjugative 62 kb IncL/
M plasmid which was so far only identified in Enterobacte-
riaceae [16]. More recently, a chromosomal location of
blaOXA-48 was reported from isolates in the UK, France,
Egypt, Lebanon and Switzerland [17-19], not only among
humans but also in fowl [20]. Interestingly, chromosomal
location of blaOXA-48 was mostly associated with E. coli D:
ST38 co-harboring blaCTX-M-24 and blaTEM-1—the same
strain type described in this study. Considering these simi-
larities, it is highly probable that the strain described in this
study also contains a chromosomally encoded blaOXA-48.
In conclusion, our study demonstrates that the prevalence
of carbapenemase-producing Enterobacteriaceae in healthy
humans in Switzerland is 0.09% (95% CI = <0.0001-0.0057)
and is associated with E. coli D:ST38. This particular strain
has previously been predominantly associated with clinical
settings [18,19,21]. Our results strongly suggest that this
epidemic clone, harboring a non-transmissible blaOXA-48
gene, is currently circulating among healthy humans. Not-
ably, this further demonstrates that the problem of the dis-
semination of blaOXA-48 positive isolates is not only related
to the epidemicity of the widely identified plasmid pOXA-
Zurfluh et al. Antimicrobial Resistance and Infection Control  (2015) 4:9 Page 2 of 3
48a [22] among different strain backgrounds, but includes
the dissemination of a single E. coli ST38 strain harboring
the blaOXA-48 gene on its chromosome. It is now even more
important that further studies are carried out in order to
survey the dissemination of carbapenemase-producing
enterobacterial strains in the population. As a strategy
for ensuring the detection of strains that exhibit low
MICs of carbapenems such as OXA-48-producers, the
use of the SUPERCARBA II may be considered highly
recommendable.
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